The 90-90-90 goals set by UN AIDS aimed to improve HIV testing and treatment by 2020, but challenges such as the COVID-19 pandemic have hindered progress. The goals have now been updated to 95-95-95 for 2025, highlighting ongoing issues in Africa including resource shortages, drug resistance, and structural violence that threaten the fight against HIV/AIDS.
In this blog post, we will explore the UN AIDS 90-90-90 goals, their evolution, and the ongoing challenges in combating the HIV/AIDS epidemic, particularly in Africa.
In 2014, UN AIDS introduced the 90-90-90 goals as a global strategy to combat HIV/AIDS, aiming for significant improvements in testing and treatment by the year 2020. The specific targets were:
These goals were designed to ensure that individuals who started ART adhered to their treatment, ultimately reducing their viral load and improving their health outcomes.
By 2020, significant progress had been made towards these goals, particularly in increasing the number of individuals receiving ART. However, substantial gaps remained, especially in achieving the critical measure of viral suppression. Recognizing these challenges, UN AIDS revised the goals to 95-95-95, with a new target date set for 2025.
The ambitious 95-95-95 goals have been jeopardized by the COVID-19 pandemic. The UN AIDS 2022 Global AIDS update, titled "In Danger," highlights the threats posed by the overlapping crises of HIV/AIDS and COVID-19. The report states:
"The Global AIDS response is under threat. Over the past two and a half years, the colliding AIDS and COVID-19 pandemics along with economic and humanitarian crises have placed the global HIV response under increasing threat."
The pandemic has disrupted health services worldwide, particularly in the global South, where health systems were already fragile. As governments grapple with new international debt constraints due to the economic downturn caused by COVID-19, the need for increased resources to recover and strengthen health systems has become critical.
The fight against HIV/AIDS in Africa faces several significant challenges:
There is a critical shortage of health workers necessary to ensure that everyone can access ART and maintain their treatment. The existing health infrastructure is weak and requires substantial funding, which has been exacerbated by the pandemic.
As individuals begin treatment with a cocktail of three antiretroviral drugs, there is a risk of developing resistance over time. This necessitates switching to second-line and potentially third-line treatments, which can be prohibitively expensive.
Adherence to treatment is a major concern, particularly in the context of food insecurity, which has worsened globally due to the pandemic. The cost and patent issues surrounding new drugs further complicate the situation.
The sustainability of funding from initiatives like PEPFAR (the U.S. President's Emergency Plan for AIDS Relief) is uncertain. There are concerns about whether this funding will continue to support those who need it most.
The poorest and most vulnerable populations are at the greatest risk of losing access to essential medicines. This situation represents a form of structural violence, where those who need treatment the most are often the least likely to receive it.
PEPFAR plays a crucial role in funding global health initiatives, with many organizations relying on its support to scale up antiretroviral treatment. While much of the funding focuses on treatment, there are also efforts directed towards prevention, education, and addressing various health issues.
In some regions, the focus is on specific subgroups, such as men who have sex with men, sex workers, and intravenous drug users. In areas with generalized epidemics, the priority is to ensure that everyone is tested and receives treatment promptly.
Preventing maternal-to-child transmission of HIV is another critical area of focus. Improving maternal and child health services, including antenatal and postnatal care, is essential to ensure that HIV-positive mothers and their children receive the necessary support.
While significant progress has been made in the fight against HIV/AIDS, particularly with the introduction of the 90-90-90 and now 95-95-95 goals, numerous challenges remain. Addressing these issues requires a concerted effort to strengthen health systems, ensure sustainable funding, and provide equitable access to treatment for all individuals affected by HIV/AIDS. The journey ahead is complex, but with continued focus and resources, there is hope for a future where the HIV/AIDS epidemic can be effectively managed and ultimately eradicated.
